Page last updated: 2024-08-24

aptiganel and Infarction, Middle Cerebral Artery

aptiganel has been researched along with Infarction, Middle Cerebral Artery in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fisher, M; Li, F; Schäbitz, WR	1

Other Studies

1 other study(ies) available for aptiganel and Infarction, Middle Cerebral Artery

Article	Year
The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats. Stroke, 2000, Volume: 31, Issue:7 Topics: Animals; Cerebral Cortex; Excitatory Amino Acid Antagonists; Guanidines; Infarction, Middle Cerebral Artery; Internal Capsule; Ischemic Attack, Transient; Male; Nerve Fibers; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury	2000

Article

Year

The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats.

Stroke, 2000, Volume: 31, Issue:7

Topics: Animals; Cerebral Cortex; Excitatory Amino Acid Antagonists; Guanidines; Infarction, Middle Cerebral Artery; Internal Capsule; Ischemic Attack, Transient; Male; Nerve Fibers; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury

2000